跳至主要内容
临床试验/NCT01148433
NCT01148433已完成不适用

Quality of Life With TESTIM® in Testosterone Replacement Therapy for Male Patients With Hypogonadism

Ferring Pharmaceuticals22 个研究点 分布在 1 个国家目标入组 157 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
157
试验地点
22
主要终点
Serum Testosterone Level

研究概览

简要总结

The present non-interventional study is to document the testosterone levels in patients with clinical symptoms such as loss of sexual desire indicating hypogonadism (testosterone deficiency syndrome). During testosterone replacement therapy with TESTIM®, the changes in the quality of life - especially with respect to motivation, activity and fatigue - of hypogonadal patients will be documented and correlated with the testosterone levels during the course of therapy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • therapeutic need according to SPC
  • written informed consent

排除标准

  • contraindications according to SPC

结局指标

主要结局

Serum Testosterone Level

时间窗: 6 months

Measured at Visit 1 (diagnosis), Visit 3 (month 3) and Visit 4 (month 6)

次要结局

  • Quality of Life - (determined by the MFI questionnaire)(6 months)
  • Multidimensional Fatigue Inventory (MFI) - (based on 20 questions regarding QoL)(6 months)
  • Loss of Libido - (determined by the International Index of Erectile Function (IIEF-5)(6 months)
  • Aging Male Scale (AMS) - (17 questions regarding the discomfort associated with testosterone deficiency)(6 months)
  • Laboratory Parameters: PSA and Haematocrit levels(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验